Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2023 Jul 31;42(36):2711. doi: 10.1038/s41388-023-02790-8

Retraction Note: Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC

Boya Zhang 1,#, Mingpeng Zhang 1,#, Yanjie Yang 1, Qi Li 1, Jianpeng Yu 1, Shimiao Zhu 1, Yuanjie Niu 1, Zhiqun Shang 1,
PMCID: PMC10473956  PMID: 37524853

Retraction to: Oncogene 10.1038/s41388-021-02103-x, published online 10 November 2021

The Editors-in-Chief have retracted this article because concerns have been raised regarding integrity of the images presented here. Specifically,

  • There appears to be overlap between the top left and top right panels of Fig. 2E.

  • There appears to be overlap between the top three panels of Fig. 2F. The bottom left and bottom right panels of Fig. 2F appear to be the same.

  • C4-2 blot in Fig. 3E appears to be the same as blot presented as LNCaP-AI in Fig. 3I.

  • There appears to be a partial overlap between two panels of Fig. 4J which are described as representing different experimental conditions.

  • Part of Fig. 5E (GAPDH blot) appears to have previously been published as part of Fig. 5E in [1] by some of the same authors.

The Editors-in-Chief therefore no longer have confidence in the reliability of the data presented in this article.

Zhiqun Shang does not agree to this retraction. Boya Zhang has not explicitly stated whether they agree to this retraction. Mingpeng Zhang, Qi Li, Jianpeng Yu, and Yuanjie Niu have not responded to correspondence about this retraction. The Publisher has not been able to obtain a current email address for Yanjie Yang or Shimiao Zhu.

Footnotes

These authors contributed equally: Boya Zhang, Mingpeng Zhang.

Reference

  • 1.Zhang B, Zhang M, Shen C, et al. LncRNA PCBP1-AS1-mediated AR/AR-V7 deubiquitination enhances prostate cancer enzalutamide resistance. Cell Death Dis. 2021;12:856. doi: 10.1038/s41419-021-04144-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Oncogene are provided here courtesy of Nature Publishing Group

RESOURCES